AMCP Statement on White House Decision to Withdraw the Rebate Rule
The Trump Administration today pulled its proposed rule to eliminate safe harbor protections for rebates paid by pharmaceutical manufacturers to PBMs and health plans in Medicare and Medicaid programs.
AMCP Partnership Forum on Prior Authorization Develops Recommendations to Improve Process
Focusing on what’s best for the patient, leveraging technology to perform real-time benefit checks, and developing trust and transparency among stakeholders are some of the suggestions to emerge from AMCP’s recent Partnership Forum on “Optimizing Prior Authorization for Appropriate Medication Selection.”
AMCP Develops Concepts for Effective Prior Authorization and Utilization Management Practices
AMCP has developed nine concepts around the effective use of prior authorization that managed care organizations can follow to ensure that PA processes are timely, transparent, collaborative and supportive of patient-centered care.
Managed Care and Specialty Pharmacy Professionals Identify Barriers and Solutions to Increasing Biosimilar Adoption
A new survey conducted by AMCP and PRIME Education assesses various strategies that managed care and specialty pharmacy professionals could adopt to overcome such barriers and boost biosimilar utilization. The results were recently published in AMCP’s Journal of Managed Care and Specialty Pharmacy.
AMCP Releases Findings of Survey on Medicare Part D MTM’s Standardized Format
According to a newly released survey from the Academy of Managed Care Pharmacy (AMCP), nearly 63 percent of Medicare beneficiaries say they would recommend medication therapy management (MTM) services provided under the Part D prescription drug program to friends and relatives.
Academy of Managed Care Pharmacy Adds Remarq® to Journal of Managed Care and Specialty Pharmacy
AMCP is now offering RedLink’s reader engagement tool Remarq for the Journal of Managed Care and Specialty Pharmacy (JMCP). Remarq, which launched on JMCP on February 25, is a platform that allows for collaboration, annotation, commenting and article sharing using editorial tools directly connected to an article’s version of record.
Academy of Managed Care Pharmacy Issues Statement on HHS’s Rebate Negotiations Proposal
Academy of Managed Care Pharmacy CEO Susan A. Cantrell, RPh, CAE, issued the following statement on the Health and Human Services Department’s (HHS’s) proposed rule to eliminate negotiated rebates for pharmaceuticals under Medicare Part D and managed Medicaid programs:
JMCP Research Highlight: Disability Drives High Prevalence of Opioid-Related Disorders in the Medicare Fee-for-Service Population
The prevalence of those diagnosed with opioid-related disorders in the Medicare fee-for-service (FFS) population — at 13.1 per 1,000 persons — is higher than among any other studied payer groups, and the majority of disorders (76.2%) were found among those receiving Medicare based on disability, according to a study in the current issue of the Journal of Managed Care & Specialty Pharmacy.